
Jinfeng laboratory holds a seminar on the development of smart pathology to accelerate the construction of ai-assisted diagnostic technology innovation system
as the "number one project" for the construction of chongqing's first laboratory and the western (chongqing) science city, jinfeng laboratory recently held a promotion meeting and development seminar on the construction of a smart pathology diagnosis center. the meeting comprehensively summarized the previous r&d results and transformation results, deeply analyzed the latest progress and development trends in the field, further clarified the development goals, and was committed to building a highland for accurate diagnosis innovation.
the meeting specially invited many leaders, experts and representatives from the pathology branch of the chinese medical association and the pathology branch of the chinese medical association to focus on disease resources and digital pathology standardization, pathology large models and intelligent diagnosis, regional cooperation and multidisciplinary collaboration, in-depth discussions were conducted on topics such as results transformation and new quality productivity cultivation.
at present, jinfeng laboratory is accelerating the construction of the "dual library and dual platform" technology system: on the one hand, it accelerates the construction of a national standardized pathological sample library and a digital pathology resource library, and has now integrated million-level full-sliced digital images; on the other hand, it has also integrated the entirely sliced digital images; , focusing on breaking through core technologies such as multimodal data fusion analysis and multi-scale pathological phenotype recognition, and successfully developed a specialized pathology large model with independent intellectual property rights, which significantly improved diagnostic efficiency.
"we are at a critical juncture in the transformation of pathological diagnosis." the laboratory head said that in the next step, we will unite domestic advantageous forces, deepen collaborative innovation, fully promote the construction of national smart pathological diagnosis centers, and promote the effective transformation of innovative technologies into new medical services. quality productivity.
- About Us
-
Research Platform
- Major Disease Sample Database
- Innovative Drug Verification And Transformation Platform
- Experimental Animal Center
- Life And Health Future Laboratory
- Biomedical Imaging Platform
- Cell Multi-Omics Platform
- Pathology Technology Platform
- Bioinformatics Research And Application Center
- Jinfeng Pathology Precision Diagnosis Center
- Research Team
- Information Center
- Join Us